Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin for Spasticity in Cerebral Palsy
NCT00060957Phase 2Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Jul 1997
- Primary completion
- Jun 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in Spasticity, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Started Jul 1997; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Spasticity
Beyond the preview
Go deeper on NCT00060957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00060957.